The incidence of ABO, Kell and Rh system blood groups in general population of Qazvin, Iran by Ahmadi, Mohammad Hossein et al.






The incidence of ABO, Kell and Rh system blood groups in general 



















1Department of Medical laboratory sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran 
2Department of Medical Biotechnology, Faculty of medicine, Babol University of Medical Sciences, Babol, Iran 
 




    Introduction:ABO antigens and the glycoproteins constituting the blood groups such as Kell and Rh 
systems are the mostly focused blood groups in transfusion medicine. Their importance is tightly 
associated with the presence of natural isoantibodies, their protein structure, and immunogenicity. The 
aim of our study was to assess the distribution of major Rh and Kell antigens and the most probable 
genotype in a normal population of Qazvin city, Iran.Materials and methods:This study was done on 
1000 healthy people who were candidates for getting driver’s license. The blood samples were tested for 
Kell, ABO and major Rh antigens by standard tube agglutination method.Results:Out of 1000 samples 
studied, the prevalence of RhD was 86.6%. The incidence of other Rh antigens i.e. C, E, c and e was 
73%, 29.8%, 72.1%, and 95.9% respectively. The most common phenotype in the samples was DCce 
and the least one was shown to be CcEe. Kell antigen frequency was 8.2%. On the other hand, 91.8% of 
people were indicated to be negative for the Kell antigen.Conclusion:Taken together, the amount of the 
individuals negative for the Kell and Rh system are adequate to provide new policies for identification 
of these antigens for both blood donors and recipients. 
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INTRODUCTION 
      Over 30 blood group systems and 600 blood 
group antigens are described since 1940 [1, 2]. 
ABO and glycoproteins are the key instructions 
in the major blood group systems such as Rh 
system and Kell which are the most important 
antigens in transfusion medicine. ABO blood 
group system has unique properties considered 
as the the most important blood group in blood 
banking procedures. Its importance is due to the 
incidence of natural isoantibodies in the sera of 
people who lack these antigens. These 
antibodies are usually IgM and can cause 
intravascular hemolysis in the cases of 
mismatch blood transfusion [3]. While the 
importance of Kell and Rh blood group systems 
is primarily due to their protein structure and 
immunogenicity. It should be noted that the 
presence of polymorphisms in the Rh antigens 
highlights its complexity [3-5]. The blood 
groups are inherited traits and usually useful for 
population genetics investigation and more 
importantly in blood banking departments and 
in the pathogenesis of hemolytic disease of 
newborns in perinatology cases [6]. In 
developing countries such as Iran during 
routine blood grouping, only ABO and RhD 
antigens are tested while other Rh antigens and 
Kell group are missed. This can increase the 
incidence of alloantibodies among general 
population especially among patients who are 
transfusion dependents such as major beta-
thalassemia and aplastic anemia and patients 
under bone marrow suppressive chemotherapies 
[7-9]. It may complicate the clinical 
manifestations of mentioned patients and also 
burden much more medical costs to the health 
systems in developing countries. Therefore, the 
aim of this study was to determine ABO, Rh 
system, and Kell phenotypic frequency in 
general population of Qazvin city in order to 
provide beneficial data for the health system 
managers, and predicting the risk of 
alloimmunization.
 




MATERIALS AND METHODS 
     This cross-sectional descriptive study was 
performed over a period of two months from 
August to September 2018. As much as 1000 
healthy people who referred to public hospital 
for health approval in order to get a driver’s 
license were selected by signing the written 
consent. ABO, Rh & Kell antigens were 
determined according to the standard cell type 
agglutination tube test using commercially 
available antisera as recommended by the 
manufacturer. Briefly, one drop of cell 
suspension (2-5%) and two drops of 
corresponding antisera were mixed. Before 
centrifugation, the tubes were incubated for 5 
minutes at room temperature. For Kell 
determination, the corresponding tubes were 
incubated in 37C˚ for 30 minutes. Then, the 
tubes were centrifuged at 1000 RPM for 1 
minute and the reactions were checked for 
agglutinations. In all the procedures, negative 
and positive controls were included. Rh-
subgroups negative or weak reactions were 
checked by microscopes and were followed by 
coomb’s test in negative cases. The ABO 
grouping results were confirmed by back 
typing. Briefly, the plasma samples were 
incubated with determined ABO cell 
suspensions at room temperature for 5 minutes 
and then centrifuged at 1000 RPM for 1 minute 
and checked for agglutination. Statistical 
analysis of the resulted data was performed by 
Microsoft office excel software. This study 
received the ethic approval from Qazvin 
University of Medical Sciences, ethic Number: 
IR.QUMS.REC.1394.220.
RESULTS 
      In this study, the participants were 63% 
female and 37% male. The subjects’ age ranged 
from 18 to 52 years old. The ABO phenotyping 
showed that O, A, B, and AB groups are the 
most and least frequent types, respectively. No 
significant difference between male and female 
groups was detected in this case. Table 1 and 2 
show ABO, Rh system, and Kell antigen 
distribution in the subjected population. In the 
Rh system, the highest frequency belonged to 
“e” antigen followed by D, C, c, and E.
 
 

























Since no genetic test was conducted on the Rh 
system in the mentioned population, according 
to the people race (white), the frequency of Rh 
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DISCUSSION 
     Comparison of our results with other studies 
from Iran is in agreement with earlier studies 
from a different province [10, 11]. However, 
there are some variations between our findings 
and other reports from different countries [2, 
12, 13]. This difference in Rh and Kell system 
distribution is clinically significant because Rh 
and Kell systems are the most clinically 
important blood groups after ABO system. 
More than 50 antigens have been identified in 
the Rh system; however, the D, C, E, e and c 
are among those which are mostly mentioned in 
clinical and population studies [4, 14]. For the 
following reasons similar studies are required in 
different parts of the world and each country: 
Determining of the frequency and organizing 
the negative blood groups 
    Given to the prevalence of important clinical 
blood groups such as Kell and Rh systems, 
blood transfusion organization will be able to 
accurately organize their resources and provide 
a national and regional reserves of negative 
blood groups, particularly in the regions with 
high prevalence of specific antigens. This will 
provide the blood supply to high-risk people 
with negative groups and those who are blood 
transfusion dependent and already have 
alloantibodies due to previous blood transfusion 
such as thalassemia patients. For example, in 
the present study, the “e” antigen with the 
prevalence of 95.5% was shown to be the most 
frequent Rh antigen in Qazvin province. This 
suggests that 4.5% of the total population lack 
this blood group and need proper blood storage. 
This issue also applies to the Kell and other 
clinically important blood groups. In a multi-
central study from Iran, Azarkeivan et al. 
screened thalassemia patients for RBC 
alloantibody formation. They reported a 
frequency of  12.1% for the alloantibodies 
against anti-Kell [15]. They also showed that 
the most double alloantibodies are against the 
combination of two Rh subgroups or 
combination of D and Kell antigens [16]. 
Anticipate and prevent the hemolytic disease 
of newborns 
     Hemolytic disease of newborns (HDN) is 
caused by blood group incompatibility between 
the mother and her fetus. In this case, the 
mother produces a specific antibody through 
immunization to the fetus blood group antigens 
which are not present in the mother’s body. A 
better understanding of the distribution of 
clinically important blood groups among 
general population and couples could help the 
relevant institutions to predict HDN and to 
prevent its adverse consequences [17]. In a 
recent study in Iran, Shahverdi et al. showed 
that 4.5% of pregnant women had formed the 
alloantibodies. Anti-D was the most common 
alloantibody constituting 70.5% of all the 
antibodies. The prevalence of alloimmunization 
other than Rh group was 14.4% [18]. 
Revision and changing policy in national 
blood banking and pre-transfusion tests 
     A better insight into the distribution of Rh 
and Kell systems in a normal population can 
also provide proper predictive policies for pre-
transfusion testing and blood banking. For 
Antigens 
 
Phenotypes Incident Genotypes Frequency 
(%) 
D C c E e DCE Rh-hr 
+ + + - + DCce R¹r DCe/dce 29 
+ + - - + DCe R¹R¹  DCe/DCe 25.8 
+ + + + + DCcEe R¹R² DCe/DcE 15.6 
+ - + - + Dce R0r Dce/dce 4.1 
+ - + + + DcEe R²r DcE/dce 8.8 
+ - + + - DcE R²R² DcE/DcE 3.4 
+ + - + + DCEe R¹Rz DCe/DCE 1.2 
+ + + + - DCcE R²Rz DcE/DCE 0.3 
- - + - + Dce Rr dce/dce 10.2 
- + + - + dCce r'r dCe/dce 1.4 
- - + + + dcEe r˝r dcE/dce 0.4 
- + - - + dCe r"r' dcE/dCe 0.6 
- + + + + dCcEe r'r' dCe/dCe <0.01* 




example, in our study, we demonstrated that co-
expression of E and c antigens among the 
population were 96%. Thus, the incidence of 
E+/c- phenotype is rare in the population. Our 
findings can help to remove the unnecessary 
routine Rh antigen typing in the populations 
who are negative for especial antigens. This 
also offers a cost-effective blood transfusion 
system and precipitates the emergency blood 
transfusion protocols. Since the normal 
population and patients in our province in a 
large extent are genetically homogenous, it is 
notable to gather valuable data on the common 
Rh genotypes, since it can lead to a better 
management of blood products and their 
distribution among high-risk patients especially 
the transfusion-dependent patients. For 
instance, DCce is the most common Rh 
phenotype in Iranian population followed by 
DCe, thus it can be predicted that the most 
common alloantibodies among transfusion-
dependent patients are anti-D and anti-E. 
Studies in Iran imply that most common 
alloantibodies in thalassemia patients are anti- 
Kell and anti- D, respectively [15, 19]. These 
findings are of a great importance due to the 
fact that the Kell antigen typing is not 
performed routinely on the blood products in 
Iran. Consistently we and others reported that 
anti-kell formation frequently occurs in blood 
recipients [15, 20]. On the other hand, as the 
availability of routine Rh typing, the anti-D 
prevalence is significantly low in Iranian 
population. This also highlights the importance 
of determining the weak or negative results in 
D typing. The significance of this confirmation 
is based on the fact that typing methods have 
different sensitivities and the results are 
influenced by many factors such as personal 
experience, test reagents etc. A negative result 
by a less sensitive method such as tube test may 
be weak or moderately positive by a more 
sensitive method like gel method. The clinical 
importance of having insights into this fact is 
that weak positive or Du individuals considered 
as Rh positive when they are selected as donors, 
and Rh negative when they are blood recipients. 
The above-mentioned fact implies that national 
policies and guidelines in Iran need to be 
revised according to the recent surveys. 
 
CONCLUSION 
     This study concludes that determining the 
prevalence of negative Kell and Rh antigens are 
crucial for taking new policies regarding the 
blood donors and recipients. This is an integral 
part of transfusion service when we are dealing 
with transfusion-dependent patients such as 
thalassemia patients. We have included the 
ABO, Rh system, and Kell antigens in this 
study, while other antigens such as Duffy and 
Kidd are also clinically important, thus further 
studies are required to elucidate the phenotypic 
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